Cardiol Therapeutics logo
Cardiol Therapeutics
CRDL | NASDAQ
Chart Builder DCF Calculator
$0.98
-$0.02 (-2.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
+$0.01 (+1.43%)
After-hours: Nov 16, 2026, 6:56 PM ET

Cardiol Therapeutics Company Profile

Company profile explained

Company Profile

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure. Cardiol Therapeutics Inc. was established in 2017 and operates from its headquarters in Oakville, Canada.

Key Executives

Name Position
David G. Elsley President, Chief Executive Officer & Director
Bernard Lim Chief Operating Officer
Christopher J. Waddick Chief Financial Officer, Corporate Secretary & Director
Andrew Warwick Hamer Chief Medical Officer and Head of Research & Development
John A. Geddes BSCPT Vice President of Corporate Development
Trevor Burns Investor Relations

Latest SEC Filings

Date Type Title
Sep 23, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 23, 2026 6-K Filing
Sep 16, 2026 SUPPL Filing
Sep 16, 2026 F-10/A [Amend] Filing
Sep 16, 2026 6-K Filing
Sep 15, 2026 6-K Filing
Sep 11, 2026 6-K Filing
Sep 10, 2026 6-K Filing
Sep 10, 2026 F-X Filing
Sep 10, 2026 F-10 Filing
View All SEC Filings ➞
Cardiol Therapeutics
Cardiol Therapeutics logo
Country Canada
IPO Date Jan 15, 2019
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 18
CEO David G. Elsley

Contact Details

2265 Upper Middle Road East Oakville, ON L6H 0G5 Canada

Stock Details

Ticker Symbol CRDL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001702123
CUSIP Number 14161Y200
ISIN Number CA14161Y2006
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.